CD4 and neoplasm: Of note, consistent with the preceding findings, both flow cytometry and immunohistochemistry demonstrated a pronounced increase in the proportion of tumor-infiltrating Th17 cells within the CD4+ T cell population in chimera-treated tumors relative to PBS controls (Fig. 4h-i).